Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia
- PMID: 9275211
- PMCID: PMC23277
- DOI: 10.1073/pnas.94.18.9831
Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia
Abstract
Vitamin D, the major steroid hormone that controls mineral ion homeostasis, exerts its actions through the vitamin D receptor (VDR). The VDR is expressed in many tissues, including several tissues not thought to play a role in mineral metabolism. Studies in kindreds with VDR mutations (vitamin D-dependent rickets type II, VDDR II) have demonstrated hypocalcemia, hyperparathyroidism, rickets, and osteomalacia. Alopecia, which is not a feature of vitamin D deficiency, is seen in some kindreds. We have generated a mouse model of VDDR II by targeted ablation of the second zinc finger of the VDR DNA-binding domain. Despite known expression of the VDR in fetal life, homozygous mice are phenotypically normal at birth and demonstrate normal survival at least until 6 months. They become hypocalcemic at 21 days of age, at which time their parathyroid hormone (PTH) levels begin to rise. Hyperparathyroidism is accompanied by an increase in the size of the parathyroid gland as well as an increase in PTH mRNA levels. Rickets and osteomalacia are seen by day 35; however, as early as day 15, there is an expansion in the zone of hypertrophic chondrocytes in the growth plate. In contrast to animals made vitamin D deficient by dietary means, and like some patients with VDDR II, these mice develop progressive alopecia from the age of 4 weeks.
Figures
Similar articles
-
Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice.Endocrinology. 1998 Oct;139(10):4391-6. doi: 10.1210/endo.139.10.6262. Endocrinology. 1998. PMID: 9751523
-
Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D.Mol Endocrinol. 2002 Jul;16(7):1524-37. doi: 10.1210/mend.16.7.0866. Mol Endocrinol. 2002. PMID: 12089348
-
Presence of a deletion mutation (c.716delA) in the ligand binding domain of the vitamin D receptor in an Indian patient with vitamin D-dependent rickets type II.Calcif Tissue Int. 2010 Jan;86(1):33-41. doi: 10.1007/s00223-009-9310-2. Epub 2009 Nov 17. Calcif Tissue Int. 2010. PMID: 19921089
-
Mechanism of vitamin D receptor action.Ann N Y Acad Sci. 2006 Apr;1068:204-13. doi: 10.1196/annals.1346.026. Ann N Y Acad Sci. 2006. PMID: 16831920 Review.
-
In vivo function of VDR in gene expression-VDR knock-out mice.J Steroid Biochem Mol Biol. 1999 Apr-Jun;69(1-6):247-51. doi: 10.1016/s0960-0760(99)00042-4. J Steroid Biochem Mol Biol. 1999. PMID: 10418998 Review.
Cited by
-
1,25-Dihydroxyvitamin D promotes negative feedback regulation of TLR signaling via targeting microRNA-155-SOCS1 in macrophages.J Immunol. 2013 Apr 1;190(7):3687-95. doi: 10.4049/jimmunol.1203273. Epub 2013 Feb 22. J Immunol. 2013. PMID: 23436936 Free PMC article.
-
Pleiotropic Activities of Vitamin D Receptors - Adequate Activation for Multiple Health Outcomes.Clin Biochem Rev. 2015 May;36(2):53-61. Clin Biochem Rev. 2015. PMID: 26224895 Free PMC article. Review.
-
Nutritionally-induced catch-up growth.Nutrients. 2015 Jan 14;7(1):517-51. doi: 10.3390/nu7010517. Nutrients. 2015. PMID: 25594438 Free PMC article. Review.
-
Cross-regulation of signaling pathways: an example of nuclear hormone receptors and the canonical Wnt pathway.Exp Cell Res. 2010 Jul 1;316(11):1763-72. doi: 10.1016/j.yexcr.2010.02.001. Epub 2010 Feb 6. Exp Cell Res. 2010. PMID: 20138864 Free PMC article. Review.
-
Endogenous retinoids in the hair follicle and sebaceous gland.Biochim Biophys Acta. 2012 Jan;1821(1):222-9. doi: 10.1016/j.bbalip.2011.08.017. Epub 2011 Sep 3. Biochim Biophys Acta. 2012. PMID: 21914489 Free PMC article. Review.
References
-
- Li Y, Bergwitz C, Jüppner H, Demay M. Endocrinology. 1997;138:2347–2353. - PubMed
-
- Johnson J A, Grande J P, Roche P C, Kumar R. J Bone Miner Res. 1996;11:56–61. - PubMed
-
- Elaroussi M A, Uhland-Smith A, Hellwig W, DeLuca H F. Biochim Biophys Acta. 1994;1192:1–6. - PubMed
-
- Tuan R S, Suyama E. J Nutr. 1996;126:1308S–1316S. - PubMed
-
- Stumpf W E, Sar M, Reid F A, Tanaka Y, DeLuca H F. Science. 1979;206:1188–1190. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases